• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.23%

    More On AZN

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    AstraZeneca PLC (AZN)

    -NYSE
    68.51 Up 0.63(0.93%) May 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:67.88
    Open:68.62
    Bid:67.80 x 100
    Ask:71.20 x 100
    1y Target Est:75.97
    Beta:0.89
    Next Earnings Date:N/A
    Day's Range:68.50 - 68.94
    52wk Range:64.26 - 81.19
    Volume:910,095
    Avg Vol (3m):1,408,350
    Market Cap:86.54B
    P/E (ttm):70.12
    EPS (ttm):0.98
    Div & Yield:3.80 (5.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AZNUp 0.93%86.54B
    GSKUp 0.80%111.47B
    MRKUp 1.30%171.52B
    PFEUp 0.70%210.74B

    Key Statistics

    Forward P/E (1 yr):16.79
    P/S (ttm):3.29
    Ex-Dividend Date:18-Feb-15

    Analysts

    Annual EPS Est (Dec-15) :4.21
    Quarterly EPS Est (Jun-15) :1.03
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):5.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback